Literature DB >> 17470837

Trials that matter: CD4+ T-lymphocyte count-guided interruption of antiretroviral therapy in HIV-infected patients.

Jeffrey M Jacobson, Barbara J Turner, Elias Abrutyn.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17470837     DOI： 10.7326/0003-4819-146-9-200705010-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

Review 1.  Novel targets for antiretroviral therapy: clinical progress to date.

Authors:  Birgitt Dau; Mark Holodniy
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.

Authors:  Jean-Pierre Routy; Mohamed-Rachid Boulassel; Bader Yassine-Diab; Charles Nicolette; Don Healey; Renu Jain; Claire Landry; Oleg Yegorov; Irina Tcherepanova; Tamara Monesmith; Lothar Finke; Rafick-Pierre Sékaly
Journal:  Clin Immunol       Date:  2009-11-04       Impact factor: 3.969

3.  Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.

Authors:  James H Willig; Sarah Abroms; Andrew O Westfall; Justin Routman; Sunil Adusumilli; Mohit Varshney; Jeroan Allison; Ashlee Chatham; James L Raper; Richard A Kaslow; Michael S Saag; Michael J Mugavero
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.